Cargando…
HO-1 promotes resistance to an EZH2 inhibitor through the pRB-E2F pathway: correlation with the progression of myelodysplastic syndrome into acute myeloid leukemia
BACKGROUND: Myelodysplastic syndrome (MDS) can progress to acute myeloid leukemia (AML), and conventional chemotherapy (decitabine) does not effectively inhibit tumor cells. Enhancer of zeste homologue 2 (EZH2) and Heme oxygenase-1 (HO-1) are two key factors in patients resistance and deterioration....
Autores principales: | He, Zhengchang, Zhang, Siyu, Ma, Dan, Fang, Qin, Yang, Liping, Shen, Shaoxian, Chen, Ying, Ren, Lingli, Wang, Jishi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6849246/ https://www.ncbi.nlm.nih.gov/pubmed/31711520 http://dx.doi.org/10.1186/s12967-019-2115-9 |
Ejemplares similares
-
CDK4, pRB and E2F1: connected to insulin
por: Fajas, Lluis, et al.
Publicado: (2010) -
E2F-1 binding affinity for pRb is not the only determinant of the E2F-1 activity
por: Sahin, Fikret, et al.
Publicado: (2010) -
Relevance of pRB Loss in Human Malignancies
por: Mandigo, Amy C., et al.
Publicado: (2022) -
Phosphorylation of pRb: mechanism for RB pathway inactivation in MYCN‐amplified retinoblastoma
por: Ewens, Kathryn G., et al.
Publicado: (2017) -
Roles of pRB in the Regulation of Nucleosome and Chromatin Structures
por: Uchida, Chiharu
Publicado: (2016)